Quality‑by‑Design Approach to Stability Indicating Method Development for Linagliptin Drug Product

GAIN GREATER CONFIDENCE AGILENT SOLUTIONS FOR QUALITY-BY-DESIGN IMPLEMENTATION IN PHARMACEUTICAL DEVELOPMENT Primer CONTENTS INTRODUCTION: AN OVERVIEW OF QUALITY BY DESIGN......................................................................................3 ELIMINATING VARIABILITY IN ANALYTICAL METHOD DEVELOPMENT...........................................................................5 Automated Method Development Solution with Multivariate Analysis for Evaluation of Design Space...................................................................................................... 7 Instrument…

QbD Based Method Development on an Agilent 1290 Infinity UHPLC System Combined with a Seamless Method Transfer to HPLC Using Intelligent System Emulation Technology Application Note Pharmaceutical QA/QC Author Abstract Vinayak A.K In this Application Note, a method was developed…

Automated QbD-Based Method Development and Validation of Oxidative Degraded Atorvastatin Application Note Pharmaceutical QA/QC Authors Abstract Vinayak AK and Syed Salman Lateef Quality-by-Design (QbD) approach emphasizes risk management and sound Agilent Technologies Inc, science. Its application in analytical method development…

Peptide Mapping: A Quality by Design (QbD) Approach Application Note Bio-Pharmaceutical Authors Abstract Sreelakshmy Menon and Peptide mapping is a widely used technique for the characterization of proteins. Suresh babu C.V. This Application Note demonstrates a robust LC method and…